Viewing Study NCT00860561


Ignite Creation Date: 2025-12-24 @ 12:05 PM
Ignite Modification Date: 2026-04-07 @ 7:48 AM
Study NCT ID: NCT00860561
Status: COMPLETED
Last Update Posted: 2014-10-10
First Post: 2009-03-11
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Faslodex Post Marketing Surveillance
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module